More News! 18 Nov 2022
Triastek cleared for 3D printed medicine treatment of ulcerative colitis
Triastek, Inc. has received clearance for its Investigational New Drug (IND) application from the United States Food and Drug Administration (FDA) to initiate clinical studies of the 3D printed medicine,…